Combination Therapy Using IL-2/IL-2 Monoclonal Antibody Complexes, Rapamycin, and Islet Autoantigen Peptides Increases Regulatory T Cell Frequency and Protects against Spontaneous and Induced Type 1 Diabetes in Nonobese Diabetic Mice
2015 ◽
Vol 195
(11)
◽
pp. 5203-5214
◽
Keyword(s):
T Cell
◽